Following the first sale of Yutrepia to treat certain types of PH, Liquidia has received $50 million under its financing ...

Columnist Anna Jeter is delighted to find themes that are relevant to her life in the fictional narratives of writers and ...

A Phase 3 clinical trial testing the experimental daily oral treatment ralinepag in people with PAH has completed enrollment.

Gradient Denervation Technologies, a company that makes an ultrasound device for PH, will join an FDA program to speed device ...

Adding Winrevair treatment significantly reduced the risk of clinical worsening in people with a recent PAH diagnosis, per a ...

With patient enrollment now complete, topline results are expected early next year from a Phase 3 trial testing PAH treatment ...

A fall and subsequent injury left columnist Jen Cueva with lots of downtime to ponder self-care and the importance of ...

Beyond Air has submitted a supplement application for its second-generation LungFit PH 2 device for treating PPHN.

Pulmonary hypertension (PH) is a rare lung disease characterized by high blood pressure in the pulmonary arteries, which deliver blood from the heart to the lungs.The high pressure causes the heart to ...

Pulmonary hypertension (PH) is rare, life-threatening lung disorder that affects the pulmonary arteries, which are responsible for transporting the blood from the right heart ventricle to the lungs.

Bionews Staff Bionews, the owner and publisher of this site, employs science writers and editors, most of whom have PhDs in the life sciences, as well as veteran journalists, who ensure stories are ...